FDA NDC Directory · JSON-LD · Markdown

Pentoxifylline

NDC 16571-856 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerRising Pharma Holdings, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA074425
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsPENTOXIFYLLINE (400 mg/1)
Marketing started20240611
Package count3

External sources

Source: openFDA. Public-domain (CC0).